OKUR   $7.465  -4.42% Market Closed

Onkure Therapeutics Inc
Total Cash 18.63M
totalCashPerShare 13.919
EBITDA -43.28M
Total Debt 6.43M
quickRatio 1.435
currentRatio 1.833
Total Revenue
debtToEquity 102.929
Revenue/Share
ROA
ROE
grossProfits
freeCashflow
operatingCashflow -36.00M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 139.43M
forwardPE -3.4659579
floatShares 419.77K
sharesOutstanding 12.65M
sharesShort 693.81K
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut 0.05%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.59%
Short Ratio help_outline 7.73%
shortPercentOfFloat
impliedSharesOutstanding
bookValue -92.311
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -42.12M
trailingEps -3.16%
forwardEps -4.70%
enterpriseToEbitda -3.22
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.03 3Q 2024
institutionsCount 89
lastUpdated Nov. 2, 2024, 10:18 a.m.